Hyasynth Bio

Developer of cannabinoid products intended to treat neurological disorders

placeMontreal, Montreal, Canada calendar_todayFounded 2014 groups18 employees language hyasynthbio.com

Registered entities

Investor mix

12 investors on record; lead investors include Anges Quebec, Organigram, SOSV.

Investor typeCountShare
Venture capital325%
Private equity217%
Angel & family office18%
Accelerator & incubator325%
Other / undisclosed325%
Coming soon